You are viewing the site in preview mode
Skip to main content
|
Types
|
HSIL
|
LSIL
|
Normal
|
Total
|
|---|
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
|---|
|
Total
|
1745
| |
1354
| |
35
| |
3134
| |
|
Total HPV (+)
|
1640
|
93.98%
|
1195
|
88.26%
|
20
|
57.14%
|
2803
|
89.44%
|
|
HPV6,11
|
36
|
2.20%
|
64
|
5.36%
|
4
|
20.00%
|
104
|
3.71%
|
|
HPV16
|
926
|
56.46%
|
289
|
24.18%
|
8
|
40.00%
|
1223
|
43.63%
|
|
HPV18
|
120
|
7.32%
|
132
|
11.05%
| | |
252
|
8.99%
|
|
HPV21
|
38
|
2.32%
|
14
|
1.17%
| | |
52
|
1.86%
|
|
HPV31
|
135
|
8.23%
|
56
|
4.69%
|
5
|
25.00%
|
196
|
6.99%
|
|
HPV33
|
123
|
7.50%
|
45
|
3.77%
|
1
|
5.00%
|
169
|
6.03%
|
|
HPV35
|
53
|
3.23%
|
57
|
4.77%
|
1
|
5.00%
|
111
|
3.96%
|
|
HPV39
|
70
|
4.27%
|
128
|
10.71%
| | |
198
|
7.06%
|
|
HPV45
|
36
|
2.20%
|
26
|
2.18%
|
2
|
10.00%
|
64
|
2.28%
|
|
HPV51
|
126
|
7.68%
|
156
|
13.05%
|
1
|
5.00%
|
283
|
10.10%
|
|
HPV52
|
266
|
16.22%
|
263
|
22.01%
|
3
|
15.00%
|
532
|
18.98%
|
|
HPV56
|
102
|
6.22%
|
170
|
14.23%
|
1
|
5.00%
|
273
|
9.74%
|
|
HPV58
|
302
|
18.41%
|
255
|
21.34%
|
3
|
15.00%
|
560
|
19.98%
|
|
HPV59
|
71
|
4.33%
|
68
|
5.69%
|
2
|
10.00%
|
141
|
5.03%
|
|
HPV66
|
40
|
2.44%
|
71
|
5.94%
|
3
|
15.00%
|
114
|
4.07%
|
|
HPV67
|
22
|
1.34%
|
7
|
0.59%
|
2
|
10.00%
| | |
|
HPV68
|
34
|
2.07%
|
87
|
7.28%
|
1
|
5.00%
|
122
|
4.35%
|
|
HPV82
|
27
|
1.65%
|
22
|
1.84%
| | |
49
|
1.75%
|
- The proportion of HPV16 type in HSIL was significantly different from that of other high-risk type HPV, P < 0.05 (HPV58, χ2 = 30.97; HPV52, χ2 = 34.72; HPV31, χ2 = 52.94; HPV51, χ2 = 52.94)
- The proportion of HPV58 type in HSIL was significantly different from that of other high-risk type HPV, p < 0.05 (HPV16, χ2 = 30.97; HPV31, χ2 = 4.42; HPV51, χ2 = 4.42) except for HPV52, χ2 = 0.14, p = 0.71 > 0.05
- The proportion of HPV52 type in HSIL was significantly different from that of HPV16, χ2 = 34.72, p < 0.05 except for HPV58, χ2 = 0.14, p = 0.71 > 0.05; HPV31, χ2 = 3.03, p = 0.08 > 0.05; HPV51, χ2 = 3.03, p = 0.08 > 0.05
- The proportion of HPV16 type in LSIL was significantly different from that of HPV51, χ2 = 4.01, p = 0.045 < 0.05 except for HPV52, χ2 = 0.11, p = 0.72 > 0.05; HPV58, χ2 = 0.26, p = 0.611 > 0.05; HPV56, χ2 = 3.25, p = 0.071 > 0.05
- The proportion of HPV52 type in LSIL was not significantly different from that of following HPV type, P > 0.05 (HPV16, χ2 = 0.11, p = 0. 72; HPV58, χ2 = 0.03, p = 0.86; HPV56, χ2 = 2.17, p = 0.14; HPV51, χ2 = 2.91, p = 0.088
- The proportion of HPV58 type in LSIL was not significantly different from that of following HPV type, P > 0.05 (HPV58, χ2 = 0.26, p = 0.61; HPV52, χ2 = 0.03, p = 0.86; HPV56, χ2 = 1.70, p = 0.19; HPV51, χ2 = 2.27, p = 0.13
- The proportion of HPV16 type in normal cervical lesion was significantly different from that of following HPV type, P < 0.05 (HPV31, χ2 = 5.13, p = 0.024; HPV6,11,52,58,66, Fisher test, p < 0.0001;)
- The proportion of HPV31 type in normal cervical lesion was significantly different from HPV16, χ2 = 5.13, p = 0.024 < 0.05; except for HPV6,11,52,58,66 (Fisher test, p = 0.111 > 0.05